BioStock interview on positive phase 1b results
Date: 2024-02-12
Interview in BioStock with Alzinova’s CEO Kristina Torfgård and CSO Anders Sandberg on the positive results from our phase 1b study with ALZ-101.
Interview in BioStock with Alzinova’s CEO Kristina Torfgård and CSO Anders Sandberg on the positive results from our phase 1b study with ALZ-101.